Sort
17,828 grants matching “crispr”
Next generation of delivery platform for Prime editors based on an RNA vector for Sickle cell disease: the âall-in-oneâ vector
$217,890Patricia Devaux · Mayo Clinic Rochester · R21 · FY2024 · EB
CRISPR Cas genes and Legionella pneumophila infection
$217,845Nicholas Philip Cianciotto · Northwestern University At Chicago · R21 · FY2013 · AI
Bioinformatics Discovery of Anti-CRISPR Operons in Human Gut Microbiome
$217,788Yanbin Yin · University Of Nebraska Lincoln · R21 · FY2022 · AI
Role of the DREAM complex in the lung tumor suppression
$217,738Larisa Litovchick · Virginia Commonwealth University · R21 · FY2023 · CA
Opportunities for targeted therapies generated by APOBEC3A activity in acute myeloid leukemia
$217,726Matthew D. Weitzman · Children'S Hosp Of Philadelphia · R21 · FY2019 · CA
International Registry of Werner Syndrome
$217,700George M. Martin · University Of Washington · R01 · FY2021 · CA
Bcl-2 protein Noxa in human T cell metabolism and differentiation
$217,657Ameeta Kelekar · University Of Minnesota · R21 · FY2020 · AI
Identification of Epigenetic Regulators Mediating Resistance to FGFR Inhibition in Squamous Cell Carcinoma
$217,642Matthew Robert Ramsey · Brigham And Women'S Hospital · R21 · FY2019 · CA
Cellular Requirements for KSHV Latency in Endothelial Cells
$217,546Michael Lagunoff · University Of Washington · R21 · FY2019 · CA
Novel Mouse Resources for Diabetic Nephropathy
$217,500Akio Kobayashi · University Of Washington · R21 · FY2016 · OD
The role of granulocyte colony stimulating factor in metastatic colon cancer
$217,500Katherine T Morris · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2018 · GM
Towards The Therapeutic Implementation of New CRISPR-Cas Systems
$217,484Niles Patrick Donegan · Excision Biotherapeutics, Inc. · R43 · FY2019 · GM
Development of A Directed Evolution Platform for RNA Methyltransferases.
$217,388Huiqing Zhou · Boston College · R61 · FY2025 · CA
Development of A Directed Evolution Platform for RNA Methyltransferases.
$217,388Huiqing Zhou · Boston College · R61 · FY2024 · CA
Engineering a new insect cell line for human-type protein glycosylation
$217,385Carol D Blair · Glycobac, Llc · R43 · FY2018 · GM
Entry inhibition of SARS-CoV-2 by human LRRC15
$217,338Sanghyun Lee · Brown University · R21 · FY2023 · AI
CANcer Cachexia Action Network/CANCAN
$217,311Mariam Jamal-Hanjani · University College London · OT2 · FY2022 · CA
Support for the use and evaluation of large cloud-based genomic datasets.
$217,082Joe Michael Cherry · Stanford University · U24 · FY2023 · HG
Exploiting iPLA2β-modified macrophages as immunotherapy for T1D
$217,080Sasanka Ramanadham · University Of Alabama At Birmingham · R21 · FY2022 · AI
Role of GluN2A and MMPs in the CeA in Dependence-Induced Escalation of Etoh Drinking
$217,063John J Woodward · Medical University Of South Carolina · R21 · FY2022 · AA
Molecular Screening Shared Resource (MSSR)
$217,052Robert Damoiseaux · University Of California Los Angeles · P30 · FY2025 · CA
Development of transgenic protocols for the Lyme disease vector, Ixodes scapularis, for tick and tick-borne disease control
$217,008Monika Gulia-Nuss · University Of Nevada Reno · R21 · FY2019 · AI
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2023 · CA
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2022 · CA
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2025 · CA